B

Britannia Life Sciences Inc
F:L020

Watchlist Manager
Britannia Life Sciences Inc
F:L020
Watchlist
Price: 0.0345 EUR -1.43% Market Closed
Market Cap: €14.1m

Net Margin

-58.5%
Current
Improving
by 49.8%
vs 3-y average of -108.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-58.5%
=
Net Income
CA$-1.2m
/
Revenue
CA$2.1m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-58.5%
=
Net Income
€-1.2m
/
Revenue
CA$2.1m

Market Distribution

In line with most companies in Canada
Percentile
34rd
Based on 4 909 companies
34rd percentile
-58.5%
Low
-9 940 586.9% — -85.9%
Typical Range
-85.9% — 5.5%
High
5.5% — 60 777.6%
Distribution Statistics
Canada
Min -9 940 586.9%
30th Percentile -85.9%
Median -7.8%
70th Percentile 5.5%
Max 60 777.6%

Britannia Life Sciences Inc
Glance View

Market Cap
14.1m EUR
Industry
N/A

Britannia Life Sciences, Inc. is a global product development platform. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-12-01. The firm's platform offers an integrated suite of services to assist companies along their product development journey. The firm provides product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. The company is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for food authorizations. The company serves consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.

L020 Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-58.5%
=
Net Income
CA$-1.2m
/
Revenue
CA$2.1m
What is Britannia Life Sciences Inc's current Net Margin?

The current Net Margin for Britannia Life Sciences Inc is -58.5%, which is above its 3-year median of -108.3%.

How has Net Margin changed over time?

Over the last 3 years, Britannia Life Sciences Inc’s Net Margin has increased from -164.5% to -58.5%. During this period, it reached a low of -922.6% on Mar 31, 2024 and a high of 79.4% on Mar 31, 2023.

Back to Top